Abstract
Topical flurbiprofen was compared with placebo and prednisolone 0.3% in the treatment of episcleritis by a randomised double-blind trial. Seventy-seven eyes were included in the trial. Rapid spontaneous improvement in symptoms and signs was noted in the majority of cases.
There was no significant difference between the cure-rates of patients treated with flurbiprofen and placebo over a 3-week trial period. The proportion of patients treated with prednisolone 0.3% who were cured was significantly higher than in either of the other groups after 3 weeks.
Similar content being viewed by others
Article PDF
References
Watson PG, McKay DAR, Clemett RS, Wilkinson P : Treatment of episcleritis: A double-blind trial comparing betamethasone 0.1%, Oxyphenbutazone 10%, and placebo eye ointments. (1973) Brit J Ophthal 57: 866–70.
Watson PG : Doyne Memorial Lecture 1982. Trans Ophthal Soc UK, 102: 257–81.
Crook D, Collins AJ : Prostaglandin synthetase activity from human rheumatoid synovial tissues and its inhibition by non-steroidal anti-inflammatory drugs. Prostaglandins 1975, 9: 857.
Anderson J, Shackleton M : Flurbiprofen absorption in ocular tissues. Report on file, Biochemistry dept, Allergan.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lyons, C., Hakin, K. & Watson, P. Topical flurbiprofen: an effective treatment for episcleritis?. Eye 4, 521–525 (1990). https://doi.org/10.1038/eye.1990.69
Issue Date:
DOI: https://doi.org/10.1038/eye.1990.69
This article is cited by
-
Diagnose und Therapie der Episkleritis und Skleritis
Der Ophthalmologe (2016)
-
A randomised, double-blind trial of topical ketorolac vs artificial tears for the treatment of episcleritis
Eye (2005)
-
A randomised double blind trial comparing the treatment of episcleritis with topical 2-(2-hydroxy-4-methylphenyl) aminothiazole hydrochloride 0.1% (CBS 113A) and placebo
Eye (1991)